作者
AJ Ullmann, OA Cornely, J Peter Donnelly, M Akova, MC Arendrup, SEVTAP Arikan‐Akdagli, Matteo Bassetti, J Bille, T Calandra, E Castagnola, J Garbino, AH Groll, R Herbrecht, WW Hope, HE Jensen, BJ Kullberg, C Lass‐Flörl, O Lortholary, W Meersseman, G Petrikkos, MD Richardson, E Roilides, PE Verweij, C Viscoli, M Cuenca‐Estrella, ESCMID Fungal Infection Study Group (EFISG)
发表日期
2012/12
期刊
Clinical Microbiology and Infection
卷号
18
页码范围
1-8
出版商
Blackwell Publishing Ltd
简介
Clin Microbiol Infect 2012; 18 (Suppl. 7): 1–8
Abstract
The process to develop a guideline in a European setting remains a challenge. The ESCMID Fungal Infection Study Group (EFISG) successfully achieved this endeavour. After two face‐to‐face meetings, numerous telephone conferences, and email correspondence, an ESCMID task force (basically composed of members of the Society’s Fungal Infection Study Group, EFISG) finalized the ESCMID diagnostic and management/therapeutic guideline for Candida diseases. By appreciating various patient populations at risk for Candida diseases, four subgroups were predefined, mainly ICU patients, paediatric, HIV/AIDS and patients with malignancies including haematopoietic stem cell transplantation. Besides treatment recommendations, the ESCMID guidelines provide guidance for diagnostic procedures. For the guidelines, questions were formulated to phrase …
引用总数
20122013201420152016201720182019202020212022202320246151814121261367997